Cassaday & Co Wealth Management’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Cassaday & Co Wealth Management’s Portfolio GNOM Stock Details GNOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.14K	Buy	+26	New	+$1.2K	﹤0.01%	1116

Other funds holding GNOM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

OAM

Oppenheimer Asset Management New York $8.76B AUM 23.12% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

USCWA

U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return

SWP

Stratos Wealth Partners Beachwood, Ohio $8.8B AUM 21.82% 1-Year Est. Return

Armis Advisers Atlanta, Georgia $1.09B AUM 22.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

CFD

Creative Financial Designs Kokomo, Indiana $1.65B AUM 15.6% 1-Year Est. Return

Cassaday & Co Wealth Management's GNOM Position: Q1 2026 in Review

Cassaday & Co Wealth Management opened a new position in Global X Genomics & Biotechnology ETF (GNOM) in Q1 2026: 26 shares worth $1.14K. The stake represents ﹤0.01% of the portfolio and ranks #1116 among its holdings.

40 funds tracked by Wall St. Rank hold GNOM as of Q1 2026.

Cassaday & Co Wealth Management held 26 shares of Global X Genomics & Biotechnology ETF worth $1.14K as of Q1 2026.
Global X Genomics & Biotechnology ETF was a new Cassaday & Co Wealth Management position in Q1 2026.
Global X Genomics & Biotechnology ETF made up ﹤0.01% of Cassaday & Co Wealth Management's portfolio in Q1 2026, its #1116 holding.
40 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q1 2026.

Based on Cassaday & Co Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.